BioCentury
ARTICLE | Clinical News

Nascobal cyanocobalamin regulatory update

November 8, 2004 8:00 AM UTC

NSTK received an FDA approvable letter for Nascobal cyanocobalamin nasal spray to treat vitamin B-12 deficiency in patients with malabsorptive conditions. NSTK said approval is dependent on an FDA ins...